<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">patmedfar</journal-id><journal-title-group><journal-title xml:lang="ru">Пациентоориентированная медицина и фармация</journal-title><trans-title-group xml:lang="en"><trans-title>Patient-Oriented Medicine and Pharmacy</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-1924</issn><publisher><publisher-name>LLC Izdatelstvo OKI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37489/2949-1924-0074</article-id><article-id custom-type="edn" pub-id-type="custom">IWJYBW</article-id><article-id custom-type="elpub" pub-id-type="custom">patmedfar-129</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НОВЫЕ ЛЕКАРСТВА И ТЕХНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NEW DRUGS AND HEALTH TECHNOLOGIES</subject></subj-group></article-categories><title-group><article-title>Наночастицы золота для тераностики в онкологии</article-title><trans-title-group xml:lang="en"><trans-title>Gold nanoparticles for theranostic treatment of cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1791-3805</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курапов</surname><given-names>П. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurapov</surname><given-names>P. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курапов Павел Борисович — д. б. н., доцент, профессор кафедры медицинских нанобиотехнологий</p><p>Москва</p></bio><bio xml:lang="en"><p>Pavel B. Kurapov — Dr. Sci. (Biol.), Professor of the Department of Medical Nanobiotechnology</p><p>Moscow </p></bio><email xlink:type="simple">kurapoff@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-7969-0819</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бахтенко</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Bakhtenko</surname><given-names>E. Ju.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бахтенко Елена Юрьевна — д. б. н., доцент, директор филиала</p><p>Ярославль</p></bio><bio xml:lang="en"><p>Elena Ju. Bakhtenko — Dr. Sci. (Biol), Docent, Branch Director</p><p>Yaroslavl </p></bio><email xlink:type="simple">bakhtenko@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н. И. Пирогова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ярославский государственный медицинский университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yaroslavl State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>03</day><month>02</month><year>2025</year></pub-date><volume>2</volume><issue>4</issue><fpage>100</fpage><lpage>104</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Курапов П.Б., Бахтенко Е.Ю., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Курапов П.Б., Бахтенко Е.Ю.</copyright-holder><copyright-holder xml:lang="en">Kurapov P.B., Bakhtenko E.J.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pomph.ru/jour/article/view/129">https://www.pomph.ru/jour/article/view/129</self-uri><abstract><p>Химическая стабильность, низкая токсичность, относительная простота методов синтеза и модификации наночастиц золота открывает широкие возможности их использования в качестве тераностических агентов для диагностики и лечения онкологических заболеваний. Уникальные свойства наночастиц золота, известные как локализованный поверхностный плазмонный резонанс, позволяют создавать на их основе тераностические агенты, сочетающие в себе возможности как диагностики in vitro, так и адресной доставки лекарств. Высокое соотношение площади поверхности к объёму наночастиц золота существенно облегчает создание на их основе комплексных наноплатформ, используемых сразу в нескольких терапевтических и диагностических направлениях.</p></abstract><trans-abstract xml:lang="en"><p>The chemical stability, low toxicity, and relative simplicity of methods for the synthesis and modification of gold nanoparticles open up wide possibilities for their use as theranostic agents for the diagnosis and treatment of cancer. The unique properties of gold nanoparticles, known as localized surface plasmon resonance, make it possible to create theranostic agents based on these nanoparticles, combining the capabilities of both in vitro diagnostics and targeted drug delivery. The high surface-area-to-volume ratio of gold nanoparticles significantly facilitates the creation of complex nanoplatforms, which can be used in several therapeutic and diagnostic areas at once.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>тераностика</kwd><kwd>наночастицы золота</kwd><kwd>локализованный поверхностный плазмонный резонанс</kwd><kwd>фототермическая терапия</kwd><kwd>адресная доставка лекарственных средств</kwd><kwd>онкология</kwd></kwd-group><kwd-group xml:lang="en"><kwd>theranostics</kwd><kwd>gold nanoparticles</kwd><kwd>localized surface plasmon resonance</kwd><kwd>photothermal therapy</kwd><kwd>targeted drug delivery</kwd><kwd>oncology</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Чехонин В.П., Баклаушев В.П., Кузнецов Д.А. Медицинские нанобиотехнологии адресной доставки диагностических и лекарственных препаратов. Вестник РГМУ. 2010;(3):6-10.</mixed-citation><mixed-citation xml:lang="en">Chekhonin VP, Baklaushev VP, Kuznetsov DA. Medical nanobiotechnology for targeted delivery of diagnostic and medicinal products. Bulletin of RSMU. 2010;(3):6-10. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Чехонин В.П., Меркулов В.А., Кузнецов Д.А., и др. Перспективы применения нанобиотехнологий в медицине. Вестник РГМУ. 2009;(1):7- 11.</mixed-citation><mixed-citation xml:lang="en">Chekhonin VP, Merkulov VA, Kuznetsov DA et al. Prospects of nanobiotechnology application in medicine. Bulletin of RSMU. 2009;(1):7-11. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Курапов П.Б., Бахтенко Е.Ю. Наночастицы золота для диагностики и терапии онкологических заболеваний. Вестник РГМУ. 2018;(6):86–93. DOI: 10.24075/vrgmu.2018.090 DOI: 10.24075/brsmu.2018.090</mixed-citation><mixed-citation xml:lang="en">Kurapov PB, Bakhtenko EY. Gold nanoparticles for diagnosis and therapy of oncological diseases. Bulletin of RSMU. 2018; (6): 79–85. DOI: 10.24075/brsmu.2018.090 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Faheem SM, Hussaina Banu. Gold Nanoparticles in Cancer Diagnosis and Treatment: A Review. Austin J Biotechnol Bioeng. 2014;1(6):1-5.</mixed-citation><mixed-citation xml:lang="en">Faheem SM, Hussaina Banu. Gold Nanoparticles in Cancer Diagnosis and Treatment: A Review. Austin J Biotechnol Bioeng. 2014;1(6):1-5.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Khan AK, Rashid R, Murtaza G, Zahra A. Gold Nanoparticles: Synthesis and Applications in Drug Delivery. Tropical Journal of Pharmaceutical Research. 2014;13(7):1169-1177. DOI:10.4314/tjpr.v13i7.23.</mixed-citation><mixed-citation xml:lang="en">Khan AK, Rashid R, Murtaza G, Zahra A. Gold Nanoparticles: Synthesis and Applications in Drug Delivery. Tropical Journal of Pharmaceutical Research. 2014;13(7):1169-1177. DOI:10.4314/tjpr.v13i7.23.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Alaqad K, Saleh TA. Gold and Silver Nanoparticles: Synthesis Methods, Characterization Routes and Applications towards Drugs. Journal of Environmental &amp; Analytical Toxicology. 2016:384. 1-10. DOI:10.4172/2161-0525.1000384.</mixed-citation><mixed-citation xml:lang="en">Alaqad K, Saleh TA. Gold and Silver Nanoparticles: Synthesis Methods, Characterization Routes and Applications towards Drugs. Journal of Environmental &amp; Analytical Toxicology. 2016:384. 1-10. DOI:10.4172/2161-0525.1000384.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Guo J, Rahme K, He Y, Li LL, Holmes JD, O'Driscoll CM. Gold nanoparticles enlighten the future of cancer theranostics. Int J Nanomedicine. 2017 Aug 22;12:6131-6152. doi: 10.2147/IJN.S140772.</mixed-citation><mixed-citation xml:lang="en">Guo J, Rahme K, He Y, Li LL, Holmes JD, O'Driscoll CM. Gold nanoparticles enlighten the future of cancer theranostics. Int J Nanomedicine. 2017 Aug 22;12:6131-6152. doi: 10.2147/IJN.S140772.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bansal SA, Kumar V, Karimi J, Singh AP, Kumar S. Role of gold nanoparticles in advanced biomedical applications. Nanoscale Adv. 2020 Jul 16;2(9):3764- 3787. doi: 10.1039/d0na00472c.</mixed-citation><mixed-citation xml:lang="en">Bansal SA, Kumar V, Karimi J, Singh AP, Kumar S. Role of gold nanoparticles in advanced biomedical applications. Nanoscale Adv. 2020 Jul 16;2(9):3764- 3787. doi: 10.1039/d0na00472c.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Дыкман Л. А., Хлебцов Н. Г. Биомедицинское применение многофункциональных золотых нанокомпозитов. Успехи биологической химии. 2016;56:411–450.</mixed-citation><mixed-citation xml:lang="en">Dykman LA, Khlebtsov NG. Biomedical application of multifunctional gold nanocomposites. Advances in biological chemistry. 2016;56:411–450. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Perry HL, Botnar RM, Wilton-Ely JDET. Gold nanomaterials functionalised with gadolinium chelates and their application in multimodal imaging and therapy. Chem Commun (Camb). 2020 Apr 14;56(29):4037-4046. doi: 10.1039/d0cc00196a.</mixed-citation><mixed-citation xml:lang="en">Perry HL, Botnar RM, Wilton-Ely JDET. Gold nanomaterials functionalised with gadolinium chelates and their application in multimodal imaging and therapy. Chem Commun (Camb). 2020 Apr 14;56(29):4037-4046. doi: 10.1039/d0cc00196a.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
